Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.013
Sell
RSI(14)
39.858
Neutral
STOCH(KDJ)(9,3,3)
26.774
Buy
ATR(14)
0.036
Low Volatility
CCI(14)
-112.023
Sell
Williams %R
67.428
Sell
TRIX(12,20)
-0.433
Sell
StochRSI(14)
99.880
Buy
Icecure Medical Ltd
ICCM0.590USD
+0.039+7.04%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
40.69MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Icecure Medical Ltd
Currency: USD Updated: 2026-02-06Key Insights
Icecure Medical Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 101 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 3.12.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Icecure Medical Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Icecure Medical Ltd Highlights
StrengthsRisks
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.29M.
Overvalued
The company’s latest PE is -2.28, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 443.26K shares, increasing 16.29% quarter-over-quarter.
Held by Ken Fisher
Star Investor Ken Fisher holds 0.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.36.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
3.125
Target Price
+466.94%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-02-06The current financial score of Icecure Medical Ltd is 6.32, ranking 162 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 850.00K, representing a year-over-year increase of 28.40%, while its net profit experienced a year-over-year increase of 6.99%.
Score
Financials
8.95
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.16
Operational Efficiency
2.83
Growth Potential
5.59
Shareholder Returns
7.07
Icecure Medical Ltd's Company Valuation
Currency: USD Updated: 2026-02-06The current valuation score of Icecure Medical Ltd is 7.17, ranking 118 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -2.28, which is -38.04% below the recent high of -1.41 and -126.11% above the recent low of -5.15.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 101/205
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-02-06The current earnings forecast score of Icecure Medical Ltd is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 3.12, with a high of 3.25 and a low of 3.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
3.125
Target Price
+466.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Icecure Medical Ltd
ICCM
2
Boston Scientific Corp
BSX
36
Intuitive Surgical Inc
ISRG
36
Edwards Lifesciences Corp
EW
35
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
18
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-02-06The current price momentum score of Icecure Medical Ltd is 6.67, ranking 105 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 0.71 and the support level at 0.51, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
0.592
Sell
MA10
0.610
Sell
MA20
0.638
Sell
MA50
0.659
Sell
MA100
0.754
Sell
MA200
0.884
Sell
Institutional Confidence
Currency: USD Updated: 2026-02-06The current institutional shareholding score of Icecure Medical Ltd is 3.00, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 0.64%, representing a quarter-over-quarter increase of 83.13%. The largest institutional shareholder is Ken Fisher, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-02-06The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Icecure Medical Ltd is 3.10, ranking 131 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 2.24. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
2.24
VaR
+7.59%
240-Day Maximum Drawdown
+63.74%
240-Day Volatility
+90.58%
Return
Best Daily Return
60 days
+8.68%
120 days
+20.80%
5 years
+734.11%
Worst Daily Return
60 days
-7.23%
120 days
-9.65%
5 years
-46.92%
Sharpe Ratio
60 days
-1.61
120 days
-1.12
5 years
+0.43
Risk Assessment
Maximum Drawdown
240 days
+63.74%
3 years
+64.44%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.91
3 years
-0.24
5 years
--
Skewness
240 days
+0.65
3 years
+5.25
5 years
+29.14
Volatility
Realised Volatility
240 days
+90.58%
5 years
--
Standardised True Range
240 days
+10.92%
5 years
--
Downside Risk-Adjusted Return
120 days
-222.99%
240 days
-222.99%
Maximum Daily Upside Volatility
60 days
+44.86%
Maximum Daily Downside Volatility
60 days
+41.21%
Liquidity
Average Turnover Rate
60 days
+2.66%
120 days
+1.56%
5 years
--
Turnover Deviation
20 days
+36.13%
60 days
+15.71%
120 days
-31.84%
Peer Comparison
Healthcare Equipment & Supplies
Icecure Medical Ltd
ICCM
6.20 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
COR
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
ALGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
